KINIKSA PHARMACEUTICALS LTD's ticker is KNSA and the CUSIP is G5269C101. A total of 139 filers reported holding KINIKSA PHARMACEUTICALS LTD in Q3 2023. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $549,691 | +11.8% | 31,646 | -9.4% | 0.00% | 0.0% |
| Q2 2023 | $491,814 | +17.5% | 34,930 | -10.2% | 0.00% | 0.0% |
| Q1 2023 | $418,392 | -29.1% | 38,884 | -1.3% | 0.00% | 0.0% |
| Q4 2022 | $589,927 | +18.2% | 39,381 | +1.4% | 0.00% | 0.0% |
| Q3 2022 | $499,000 | +30.6% | 38,840 | -1.5% | 0.00% | 0.0% |
| Q2 2022 | $382,000 | +11.7% | 39,440 | +14.6% | 0.00% | – |
| Q1 2022 | $342,000 | -20.1% | 34,410 | -5.5% | 0.00% | -100.0% |
| Q4 2021 | $428,000 | +6.2% | 36,395 | +2.8% | 0.00% | 0.0% |
| Q3 2021 | $403,000 | -28.0% | 35,406 | -12.0% | 0.00% | 0.0% |
| Q2 2021 | $560,000 | -24.9% | 40,232 | -0.2% | 0.00% | 0.0% |
| Q1 2021 | $746,000 | +4.3% | 40,310 | -0.4% | 0.00% | 0.0% |
| Q4 2020 | $715,000 | +15.3% | 40,456 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $620,000 | -15.2% | 40,456 | +41.1% | 0.00% | 0.0% |
| Q2 2020 | $731,000 | +118.9% | 28,671 | +33.0% | 0.00% | 0.0% |
| Q1 2020 | $334,000 | +41.5% | 21,558 | +1.2% | 0.00% | – |
| Q4 2019 | $236,000 | +29.0% | 21,310 | -0.8% | 0.00% | – |
| Q3 2019 | $183,000 | -37.1% | 21,481 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $291,000 | -12.3% | 21,481 | +17.0% | 0.00% | 0.0% |
| Q1 2019 | $332,000 | +20.7% | 18,364 | +87.3% | 0.00% | 0.0% |
| Q4 2018 | $275,000 | +10.0% | 9,806 | 0.0% | 0.00% | – |
| Q3 2018 | $250,000 | – | 9,806 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 2,374,392 | $36,376,000 | 4.43% |
| Opaleye Management Inc. | 338,000 | $8,778,000 | 1.72% |
| Lion Point Capital, LP | 495,748 | $7,594,000 | 1.67% |
| Fairmount Funds Management LLC | 212,746 | $3,259,000 | 1.38% |
| Vivo Capital, LLC | 1,151,622 | $17,643,000 | 1.02% |
| Spearhead Capital Advisors, LLC | 270,117 | $4,138,000 | 0.79% |
| Integral Health Asset Management, LLC | 120,000 | $1,838,000 | 0.56% |
| Endurant Capital Management LP | 117,480 | $1,800,000 | 0.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 259,990 | $3,983,000 | 0.39% |
| Ikarian Capital, LLC | 342,998 | $5,254,000 | 0.38% |